IRIS
Lughezzani, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.369
AS - Asia 9.055
EU - Europa 3.487
SA - Sud America 2.076
AF - Africa 514
Continente sconosciuto - Info sul continente non disponibili 378
OC - Oceania 25
Totale 31.904
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.979
SG - Singapore 5.464
BR - Brasile 1.684
CN - Cina 1.468
IT - Italia 1.207
VN - Vietnam 1.014
FI - Finlandia 494
IE - Irlanda 388
NG - Nigeria 327
DE - Germania 318
HK - Hong Kong 260
FR - Francia 258
GB - Regno Unito 221
CA - Canada 206
AR - Argentina 152
IN - India 141
NL - Olanda 124
TR - Turchia 114
BD - Bangladesh 104
SE - Svezia 89
MX - Messico 85
RU - Federazione Russa 83
ID - Indonesia 72
EC - Ecuador 66
IQ - Iraq 58
JP - Giappone 58
ZA - Sudafrica 54
UA - Ucraina 44
CL - Cile 41
VE - Venezuela 41
ES - Italia 37
CO - Colombia 35
IL - Israele 34
PL - Polonia 32
SA - Arabia Saudita 29
PH - Filippine 28
EG - Egitto 27
PK - Pakistan 27
PY - Paraguay 27
AU - Australia 25
UZ - Uzbekistan 25
KE - Kenya 23
DZ - Algeria 22
RO - Romania 22
MA - Marocco 20
MK - Macedonia 20
MY - Malesia 20
BE - Belgio 19
NP - Nepal 19
CZ - Repubblica Ceca 17
AT - Austria 16
JO - Giordania 16
TT - Trinidad e Tobago 16
CH - Svizzera 14
AE - Emirati Arabi Uniti 12
JM - Giamaica 12
KZ - Kazakistan 12
TN - Tunisia 12
TW - Taiwan 12
HN - Honduras 11
PE - Perù 11
UY - Uruguay 11
CR - Costa Rica 10
DO - Repubblica Dominicana 10
A2 - ???statistics.table.value.countryCode.A2??? 9
LT - Lituania 9
PT - Portogallo 9
GR - Grecia 8
IR - Iran 8
MO - Macao, regione amministrativa speciale della Cina 8
AZ - Azerbaigian 7
BO - Bolivia 7
ET - Etiopia 7
LB - Libano 7
PS - Palestinian Territory 7
TH - Thailandia 7
AL - Albania 6
HU - Ungheria 6
PR - Porto Rico 6
AO - Angola 5
CG - Congo 5
GT - Guatemala 5
MD - Moldavia 5
NI - Nicaragua 5
PA - Panama 5
RS - Serbia 5
BG - Bulgaria 4
BS - Bahamas 4
DK - Danimarca 4
KG - Kirghizistan 4
NO - Norvegia 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
SV - El Salvador 4
BA - Bosnia-Erzegovina 3
BY - Bielorussia 3
EE - Estonia 3
EU - Europa 3
GD - Grenada 3
HR - Croazia 3
Totale 31.493
Salva come PNG Salva come JPEG
Città #
Singapore 2.417
Wilmington 1.835
Chandler 1.316
Ashburn 935
San Jose 821
The Dalles 800
San Mateo 717
Shanghai 607
Dallas 589
Milan 577
Ann Arbor 512
Helsinki 491
Council Bluffs 472
Dublin 385
Princeton 353
Ho Chi Minh City 335
Leawood 330
Lawrence 328
Benin City 325
Beijing 322
New York 298
Santa Clara 280
Hong Kong 237
Hanoi 234
Boardman 222
Los Angeles 220
Paris 195
Fairfield 189
Woodbridge 188
Rome 184
Phoenix 119
São Paulo 105
Amsterdam 95
London 95
Buffalo 83
Toronto 83
Kocaeli 66
Orem 60
Rio de Janeiro 60
Seattle 59
Da Nang 54
San Diego 54
Chicago 53
Haiphong 52
Atlanta 51
Figino 51
Columbus 48
Brooklyn 46
Philadelphia 40
Belo Horizonte 38
Norwalk 38
Brasília 36
Naples 35
Queens 31
Falkenstein 30
Campinas 29
Curitiba 29
Houston 29
Montreal 29
Las Vegas 27
Munich 27
Pune 27
Charlotte 26
Cincinnati 25
Mexico City 25
Frankfurt am Main 24
Manchester 24
Miami 24
Biên Hòa 23
Johannesburg 23
Porto Alegre 23
Tashkent 23
Tokyo 23
Warsaw 23
Chennai 22
Guayaquil 22
Turin 22
Nairobi 21
Pittsburgh 21
Richmond 21
Salvador 21
Boston 20
Thái Bình 20
Denver 19
Falls Church 19
Guarulhos 19
Jacksonville 19
New Delhi 19
Quito 19
Moscow 18
Orlando 18
Santiago 18
Brussels 17
Hải Dương 17
Ribeirão Preto 16
Riverside 16
Sacramento 16
Des Moines 15
Dhaka 15
San Francisco 15
Totale 19.164
Salva come PNG Salva come JPEG
Nome #
Outcome of Sars-COV-2-related thyrotoxicosis in survivors of Covid-19: a prospective study 232
"En Bloc" Resection of Nonmuscle Invasive Bladder Cancer: A Prospective Single-center Study 198
Radical prostatectomy represents an effective treatment in patients with specimen-confined high pathological Gleason score prostate cancer. 198
Active surveillance for low-risk Non-Muscle Invasive Bladder Cancer (NMIBC): mid-term results from a Bladder cancer Italian Active Surveillance (BIAS) project. 190
137 PHI (Prostate Health Index) and %p2PSA for prediction of prostate cancer in men younger than 60 years of age. A nested-case control study from PROpsa Multicentric European Study (PROMEtheuS project) 169
855 Definition of the Limit of Detection (LoD) for serum isoform [−2]proPSA in patients with recurrent prostate cancer after radical prostatectomy: An analytic study 161
Genomewide Association Study of Severe Covid-19 with Respiratory Failure 150
Active Surveillance for Low Risk Nonmuscle Invasive Bladder Cancer: A Confirmatory and Resource Consumption Study from the BIAS Project 149
Two-dimensional neovascular complexity is significantly higher in nontumor prostate tissue than in low-risk prostate cancer 145
Accuracy of p2PSA and derivatives (%p2PSA and PHI) in predicting prostate cancer in obese men from a multicenter European study 145
Ga-68-PSMA Positron Emission Tomography/Computerized Tomography for Primary Diagnosis of Prostate Cancer in Men with Contraindications to or Negative Multiparametric Magnetic Resonance Imaging: A Prospective Observational Study 144
63 Preoperative predictors of positive surgical margins in a contemporary cohort of patients treated with bilateral nerve sparing robot assisted laparoscopic radical prostatectomy 144
[-2]PROPSA FOR PREDICTION OF EARLY BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY: PRELIMINARY RESULTS FROM AN OBSERVATIONAL COHORT STUDY 142
254 Margin, Ischemia, and Complications (MIC) System to report perioperative outcomes of robot-assisted partial nephrectomy: A European Multicenter Observational Study (EMOS project) 142
-2PROPSA, %-2PROPSA AND PHI (PROSTATE HEALTH INDEX) CORRELATE WITH CANCER AGGRESSIVENESS IN PATIENTS WHO UNDERWENT RADICAL PROSTATECTOMY 140
68GA-PSMA PET/CT FOR PRIMARY DIAGNOSIS OF PROSTATE CANCER IN MEN WITH CONTRAINDICATIONS TO OR NEGATIVE MRI: A PROSPECTIVE OBSERVATIONAL STUDY 139
An observational study of the use of beclomethasone dipropionate suppositories in the treatment of lower urinary tract inflammation in men 138
54 Safety and efficacy of robot-assisted laparoscopic partial nephrectomy during the learning curve in a high volume urological center 137
[Focal therapy and prostate cancer]. 136
Re: Comparative Analysis of Transperineal Template Saturation Prostate Biopsy Versus Magnetic Resonance Imaging Targeted Biopsy with Magnetic Resonance Imaging-Ultrasound Fusion Guidance 133
Long-term oncologic outcomes of laparoscopic renal cryoablation as primary treatment for small renal masses 132
Clinical and pathological predictors of persistent T1 HG at second resection 130
Clinical use of [-2]proPSA (p2PSA) and its derivatives (%p2PSA and Prostate Health Index) for the detection of prostate cancer: a review of the literature. 130
arallel comparison of 68Ga-Prostate Specific Membrane Antigen PET-CT and PRIMUS in primary prostate cancer diagnosis 129
Xpert Bladder Cancer Detection in Emergency Setting Assessment (XESA Project): A Prospective, Single-centre Trial 123
Role of Restaging Transurethral Resection for T1 Non-muscle invasive Bladder Cancer: A Systematic Review and Meta-analysis 123
[-2]PROPSA (P2PSA) AND ITS DERIVATIVES %P2PSA AND PHI (PROSTATE HEALTH INDEX) IN A REAL CLINICAL SETTING OF CONTEMPORARY MEN UNDERGOING PROSTATE BIOPSY FOR SUSPECTED PROSTATE CANCER. A SINGLE HIGH-VOLUME CENTER EXPERIENCE 120
[The added value of robotic surgery]. 120
Clinical performance of Xpert Bladder Cancer (BC) Monitor, a mRNA-based urine test, in active surveillance (AS) patients with recurrent non-muscle-invasive bladder cancer (NMIBC): results from the Bladder Cancer Italian Active Surveillance (BIAS) project 119
Application and Uses of Electronic Noses for Clinical Diagnosis on Urine Samples: A Review 119
Reliability of the da Vinci robotic surgical system: a systematic review and pooled analysis of technical failures 116
Margin, Ischemia, and Complications System to Report Perioperative Outcomes of Robotic Partial Nephrectomy: A European Multicenter Observational Study (EMOS Project) REPLY 116
Managing chronic bladder diseases with the administration of exogenous glycosaminoglycans: an update on the evidence 114
Re: Guazzoni et al.: Oncologic Results of Laparoscopic Renal Cryoablation for Clinical T1a Tumors: 8 Years of Experience in a Single Institution (Urology 2010; 76: 624-629) Reply 113
Oncological outcomes and complication rates after laparoscopic-assisted cryoablation: a European Registry for Renal Cryoablation (EuRECA) multi-institutional study 113
HOW TO SIMPLIFY PATIENT POSITIONING AND PORT PLACEMENT DURING ROBOTIC ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY (RALP) 111
Relationship of Chronic Histologic Prostatic Inflammation in Biopsy Specimens With Serum Isoform [-2]proPSA (p2PSA), %p2PSA, and Prostate Health Index in Men With a Total Prostate-specific Antigen of 4-10 ng/mL and Normal Digital Rectal Examination 111
ACTIVE SURVEILLANCE FOR NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC): RESULT FROM BLADDER CANCER ITALIAN ACTIVE SURVEILLANCE (BIAS) PROJECT 111
A Critical Appraisal of the Value of Lymph Node Dissection at Nephroureterectomy for Upper Tract Urothelial Carcinoma REPLY 111
Evaluation of positive surgical margins in patients undergoing robot-assisted and open radical prostatectomy according to preoperative risk groups 110
A Population-based Analysis of the Rate of Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma in the United States 110
A comparative population-based analysis of the rate of partial vs radical nephrectomy for clinically localized renal cell carcinoma 109
A Critical Appraisal of the Value of Lymph Node Dissection at Nephroureterectomy for Upper Tract Urothelial Carcinoma 109
Prostate-Specific Antigen (PSA) Isoform p2PSA Significantly Improves the Prediction of Prostate Cancer at Initial Extended Prostate Biopsies in Patients with Total PSA Between 2.0 and 10 ng/ml: Results of a Prospective Study in a Clinical Setting 108
Ga-68-PSMA PET/CT for primary diagnosis of prostate cancer in men with contraindications to or negative mpMRI 108
LIQUID BIOPSY BY PROSTATE-DERIVED TUMOR CELLS ENRICHED FROM SEMINAL FLUID (SF): THE SEMEN PROSTATE CANCER TUMOR ELEMENTS (SPECTRE) PROJECT. 108
The Management of Small Renal Masses: Renal Anatomy and Physiology 108
DIAGNOSTIC ACCURACY OF [-2]PROPSA (P2PSA) AND ITS DERIVATIVES %P2PSA AND PHI (PROSTATE HEALTH INDEX) IN A REAL CLINICAL SETTING OF CONTEMPORARY MEN UNDERGOING PROSTATE BIOPSY FOR SUSPECTED PROSTATE CANCER 106
Nephroureterectomy and segmental ureterectomy in the treatment of invasive upper tract urothelial carcinoma: A population-based study of 2299 patients 105
A POPULATION-BASED ANALYSIS OF PERIOPERATIVE COMPLICATIONS AND MORTALITY ASSOCIATED WITH CYTOREDUCTIVE NEPHRECTOMY FOR METASTATIC RENAL CELL CARCINOMA 105
Impact of prostate cancer screening in European ancestry un‐affected men with germline DNA repair pathogenic variants 104
IMPACT OF MINIMALLY INVASIVE APPROACH ON THE PROBABILITY OF EARLY COMPLETE FUNCTIONAL RECOVERY AFTER BILATERAL NERVE SPARING RADICAL PROSTATECTOMY 104
Clinical performance of prostate health index in men with tPSA>10ng/ml: Results from a multicentric European study. 104
Targeted PET/TRUS software fusion‑guided biopsy in men with persistently elevated PSA and negative mpMRI after previous negative biopsy: A feasibility study and preliminary results 103
Margin, Ischemia, and Complications System to Report Perioperative Outcomes of Robotic Partial Nephrectomy: A European Multicenter Observational Study (EMOS Project) 102
Robot-assisted Surgery for Benign Ureteral Strictures: Experience and Outcomes from Four Tertiary Care Institutions 101
Functional outcomes after robot-assisted radical prostatectomy in young patients (≤ 55 yrs) with prostate cancer: Is surgery perfect in the best candidates? 101
A Contemporary Population-Based Assessment of the Rate of Lymph Node Dissection for Penile Carcinoma 101
Robot-assisted laparoscopic partial nephrectomy with Alf–X Robot on pig model 100
Preoperative prostate health index is an independent predictor of early biochemical recurrence after radical prostatectomy: Results from a prospective single-center study 100
Urethral Lift for Benign Prostatic Hyperplasia: A Comprehensive Review of the Literature 99
Highly-trained dogs' olfactory system for detecting biochemical recurrence following radical prostatectomy 99
Optimizing Prostate Cancer Diagnostic Work‐Up Through Micro‐Ultrasound: Minimizing Unnecessary Procedures and Reducing Overdiagnoses 98
Predicting Cancer-specific Mortality After Radical Prostatectomy: Still a Long Way To Go 98
Clinical performance of serum prostate-specific antigen isoform [-2]proPSA (p2PSA) and its derivatives, %p2PSA and the prostate health index (PHI), in men with a family history of prostate cancer: results from a multicentre European study, the PROMEtheuS project 98
INTRAFASCIAL BILATERAL NERVE SPARING RADICAL PROSTATECTOMY: DOES THE ROBOTIC-ASSISTED APPROACH PREDISPOSE TO HIGHER RISK OF POSITIVE SURGICAL MARGINS? IMPORTANCE OF PATIENT SELECTION 98
Long-term outcomes of high-grade T1 bladder cancer treated with intravesical bacillus Calmette-Guerin: experience of a single center 98
Ex Vivo Real-time Assessment of Detrusor Muscle Sampling via Confocal Microscopy During Endoscopic Resection of Bladder Tumor 97
Robotic assisted radical prostatectomy in morbidly obese patients: how to create a cost-effective adequate optical trocar 97
TRANSPERITONEAL LAPAROSCOPIC ADRENALECTOMY: SINGLE INSTITUTION 16-YEAR EXPERIENCE 96
Reply to Marc A. Bjurlin, Lee C. Zhao, and Michael D. Stifelman's Letter to the Editor Re: Nicolo Maria Buffi, Giovanni Lughezzani, Rodolfo Hurle, et al. Robot-assisted Surgery for Benign Ureteral Strictures: Experience and Outcomes from Four Tertiary Care Institutions. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.07.022 96
A Population-based Assessment of Perioperative Mortality After Nephroureterectomy for Upper-tract Urothelial Carcinoma 96
p2PSA for predicting biochemical recurrence of prostate cancer earlier than total prostate-specific antigen after radical prostatectomy: an observational prospective cohort study 95
Prospective evaluation of Ga-68-PSMA PET/CT in primary prostate cancer diagnosis - final results of a dedicated trial 95
Predictive factors for progression of patients with carcinoma in situ of the bladder at long-term follow-up: Pure versus non-pure CIS 95
Preoperative prostate-specific antigen isoform p2PSA and its derivatives, %p2PSA and prostate health index, predict pathologic outcomes in patients undergoing radical prostatectomy for prostate cancer 95
Xpert Bladder Cancer Monitor May Avoid Cystoscopies in Patients Under "Active Surveillance" for Recurrent Bladder Cancer (BIAS Project): Longitudinal Cohort Study 94
POPULATION-BASED COMPARISON OF CANCER SPECIFIC MORTALITY AFTER LOCAL TUMOR ABLATION OR NON-ACTIVE TREATMENT FOR T1A KIDNEY CANCER: A COMPETING RISK ANALYSIS 94
Oncologic results of laparoscopic renal cryoablation for clinical T1a tumors: 8 years of experience in a single institution. 94
How Should We Report Incontinence After Radical Prostatectomy? 93
Is Robotic Surgery Unnecessary for Adrenalectomy? Weighting the Pros and Cons of the Robotic Approach 93
Bladder Cancer and Urothelial Impairment: The Role of TRPV1 as Potential Drug Target 93
A population-based competing-risks analysis of survival after nephrectomy for renal cell carcinoma 92
Nephron-sparing Surgery Is Equally Effective to Radical Nephrectomy for T1BN0M0 Renal Cell Carcinoma: A Population-based Assessment 92
Robot-assisted, Single-site, Dismembered Pyeloplasty for Ureteropelvic Junction Obstruction with the New da Vinci Platform: A Stage 2a Study 92
P2PSA AND DERIVATIVES (% P2PSA AND PHI) ACCURATELY PREDICT PROSTATE CANCER IN OBESE MEN FROM A MULTICENTER PROSPECTIVE EUROPEAN STUDY 91
Serum Index Test %[-2]proPSA and Prostate Health Index are More Accurate than Prostate Specific Antigen and %fPSA in Predicting a Positive Repeat Prostate Biopsy 90
Should Bladder Cuff Excision Remain the Standard of Care at Nephroureterectomy in Patients with Urothelial Carcinoma of the Renal Pelvis? A Population-based Study 90
Long-term Follow-up and Factors Associated with Active Surveillance Failure for Patients with Non-muscle-invasive Bladder Cancer: The Bladder Cancer Italian Active Surveillance (BIAS) Experience 90
MIDDLE TERM FOLLOW-UP RESULTS OF MAGNETIC RESONANCE IMAGING EVALUATION AFTER FOCAL THERAPY FOR PROSTATE CANCER 89
UROLOGIST LEARNING CURVE HAS AN IMPACT ON INCREASING PROBABILITY OF CLINICALLY SIGNIFICANT CANCER DETECTION RATE AT MPMRI-TRUS FUSION TARGET BIOPSY: A PROSPECTIVE STUDY IN A SINGLE HIGH VOLUME INSTITUTION 89
Multicenter European External Validation of a Prostate Health Index-based Nomogram for Predicting Prostate Cancer at Extended Biopsy 89
Correlation of chronic histologic prostatic inflammation (CHPI) in biopsy specimens with serum isoform [-2]proPSA (p2PSA), %p2PSA and PHI (prostate health index) in men undergoing prostate biopsy for suspected PCa 89
Preoperative Pelvic Floor Muscle Exercise for Early Continence After Radical Prostatectomy: A Randomised Controlled Study 89
XPERTBLADDER MONITOR TEST FOR FAILURE DEFINITION OF PATIENTS UNDER ACTIVE SURVEILLANCE FOR RECURRENT LOW-RISK NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) WITH NEGATIVE CITOLOGY 89
Location of the Primary Tumor is Not an Independent Predictor of Cancer Specific Mortality in Patients With Upper Urinary Tract Urothelial Carcinoma 89
Clinical performance of the Prostate Health Index (PHI) for the prediction of prostate cancer in obese men: data from the PROMEtheuS project, a multicentre European prospective study 89
Limited Prognostic Value of Tumor Necrosis in Patients With Renal Cell Carcinoma 89
Clinical performance of serum isoform [-2]proPSA (p2PSA), and its derivatives %p2PSA and the Prostate Health Index, in men aged < 60 years: results from a multicentric European study 89
Case Report: Unclassified Renal Cell Carcinoma With Medullary Phenotype and SMARCB1/INI1 Deficiency, Broadening the Spectrum of Medullary Carcinoma 89
Totale 11.326
Salva come PNG Salva come JPEG
Categoria #
all - tutte 204.309
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 204.309
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.551 0 0 0 367 17 21 48 254 151 210 426 57
2022/20234.002 723 118 403 404 381 311 16 292 671 381 259 43
2023/20242.286 184 266 446 117 63 204 141 174 39 42 232 378
2024/20254.174 90 79 48 71 118 422 192 456 599 1.012 473 614
2025/202611.675 1.431 609 833 1.388 354 437 3.009 686 651 777 508 992
2026/20274.562 1.353 1.057 1.720 432 0 0 0 0 0 0 0 0
Totale 31.904